BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21398609)

  • 1. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
    Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
    J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
    Dey A; Li W
    Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH; Lee GY; Kim JI; Ham M; Won Lee J; Kim JB
    J Lipid Res; 2010 Dec; 51(12):3425-33. PubMed ID: 20847297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
    Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages.
    Shridas P; Bailey WM; Gizard F; Oslund RC; Gelb MH; Bruemmer D; Webb NR
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):2014-21. PubMed ID: 20844270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144.
    Ramírez CM; Rotllan N; Vlassov AV; Dávalos A; Li M; Goedeke L; Aranda JF; Cirera-Salinas D; Araldi E; Salerno A; Wanschel A; Zavadil J; Castrillo A; Kim J; Suárez Y; Fernández-Hernando C
    Circ Res; 2013 Jun; 112(12):1592-601. PubMed ID: 23519695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRα.
    Kiss E; Popovic Z; Bedke J; Wang S; Bonrouhi M; Gretz N; Stettner P; Teupser D; Thiery J; Porubsky S; Adams J; Gröne HJ
    Am J Pathol; 2011 Jul; 179(1):92-103. PubMed ID: 21703396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.
    Yasuda T; Grillot D; Billheimer JT; Briand F; Delerive P; Huet S; Rader DJ
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):781-6. PubMed ID: 20110577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of liver X receptor induces macrophage interleukin-5 expression.
    Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
    J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
    Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
    Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression.
    Huwait EA; Greenow KR; Singh NN; Ramji DP
    Cell Signal; 2011 Mar; 23(3):542-9. PubMed ID: 21070853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1.
    Cho MK; Suh SH; Lee CH; Kim SG
    Biochim Biophys Acta; 2005 May; 1744(1):47-57. PubMed ID: 15878397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.